OpenEvidence (DeepConsult + Visits)
Clinical decision support. Visits (Aug 2025) connects evidence layer to the live encounter — patient-specific context binding distinct from pure literature RAG. DeepConsult agent autonomously cross-references hundreds of peer-reviewed studies.
Active · Verified 2026-10-22 · fresh as of 2026-10-22 · 28 cited facts, 5 with a third-party source · 1 recorded change · Suggest a correction
At a glance
- Type
- Encounter-grounded evidence synthesis vendor fix
- Tier
- T2
- Created
- 2022 (founded 2022 by Daniel Nadler) third-party fix
- Latest release
- not applicable — not OSS fix
- License
- not applicable — not OSS fix
- GitHub
- not applicable — no GitHub repo fix
- Pricing
- Free for verified physicians/HCPs; ad-supported third-party fix
- Funding
- ~$700M+ total; $250M Series D at $12B val (2026-01); reported further $250M at $15B (2026-09, unconfirmed) third-party fix
- Freshness
- 2026-10-22 fix
- Layer
- agent-infra repo fix
- Licensing
- commercial third-party fix
Memory taxonomy
- storage
- vector
- retrieval
- similarity
- persistence
- session
- update
- read-only
- unit
- document
- governance
- inspectable
- conflict
- none
When to use
Optimised for: HIPAA compliance + clinical-grade provenance + EHR integration
Anti-fit: not for non-healthcare verticals; must operate under HIPAA / regional health regulation
Pros & cons
Pros
Most-used clinical-evidence AI in US; memory of past consults + visits feeds longitudinal care reasoning.
Cons
US-clinician scope; smaller global presence; subscription model.
Claims & capabilities
100% USMLE score. 35M peer-reviewed publications indexed.
Technical surface
- API surface
- searched not found
- Backend storage
- searched not found
- Deployment
- Managed-only (web + mobile apps)
- Embedding model
- searched not found
- Multi-tenancy
- BAA with covered entities; annual third-party network + application penetration testing
- MCP
- no MCP support advertised — vertical product, no MCP server / client integration documented
- A2A
- no A2A protocol support advertised — vertical product, no A2A integration documented
- OpenTelemetry
- no OpenTelemetry integration advertised — vendor logs/observability not publicly documented
Alternatives to OpenEvidence (DeepConsult + Visits) → live options ranked by shared design, licence, hosting and MCP support
Similar systems
Other vertical / domain-specific ai memory in the catalog, ranked by inbound references.
- Inworld AI T1
Formerly an NPC character engine with named Long-Term Memory; now sells realtime voice models (TTS-2, STT-1, speech-to-speech) and OpenAI-compatible open-model inference. Character/NPC memory is no longer the headline product.
- NVIDIA ReMEmbR T3
Builds long-horizon memory by captioning video segments with VILA, storing captions with timestamps + 3D position coordinates in MilvusDB. At query time, LLM iterates retrieval across text, time, and position modalities. Deployed on Nova Carter robot (Jetson Orin).
- Abridge T1
Clinician-assist ambient documentation. Source mapping: every AI-generated summary element traced back to the source utterance. Audit-and-trust layer over episodic memory. Built on proprietary 1.5M+ medical-encounter dataset.
- ASAPP GenerativeAgent T1
Treats memory as first-class architecture. Captures the digital footprint of every interaction; retrieves preference and history at engagement time. Public example: airline knowing a frequent flyer wants aisle seats with her son — preference-aware, not just history-lookup.
- BenevolentAI T1
Taken private: merged into Osaka Holdings (renamed BenevolentAI S.A.) and delisted from Euronext Amsterdam 2025-03-13. Target identification / drug repurposing / mechanism tracing. 85+ data sources, petabyte-scale, rebuilt every few weeks. Wet-lab results re-enter the graph and shift downstream predictions — institutional experimental memory closing a feedback loop. As of Oct 2026 benevolent.com leads with Qor, powered by BenevolentAI, a life-science intelligence service for biopharma decision makers and consultancies. Qor (qor.one) is a continuously updated decision-intelligence service built on BenevolentAI's knowledge graph and reasoning methods: it tracks evidence on an asset or indication (competitive position, rival readouts, comparable deals), source-verifies each claim and flags when an earlier conclusion stops holding. It targets biotech teams and life-science consultancies.
- Causaly T1
Agentic AI platform for life sciences: orchestrated scientific agents over a curated biomedical knowledge graph (plus Bio Graph and Pipeline Graph), an evidence-retrieval system and an enterprise data fabric over literature, trials and patents.
Sources (27 cited facts, 5 third-party)
Each fact links to the page it came from; the badge says who published it (how to read sources).
- What it is Encounter-grounded evidence synthesis vendor
- What it does & what's distinct Clinical decision support. Visits (Aug 2025) connects evidence layer to the live encount… vendor
- Claims / benefits 100% USMLE score. 35M peer-reviewed publications indexed. vendor
- Modalities text vendor
- Created 2022 (founded 2022 by Daniel Nadler) third-party
- Funding ~$700M+ total; $250M Series D at $12B val (2026-01); reported further $250M at $15B (202… third-party
- Pricing Free for verified physicians/HCPs; ad-supported third-party
- Deployment Managed-only (web + mobile apps) third-party
- Memory volume / scale 35M peer-reviewed publications indexed (vendor claim) vendor
- Multi-tenancy BAA with covered entities; annual third-party network + application penetration testing vendor
- Encryption AES-256 at rest, TLS 1.2 with SHA-256 certificate in transit; SOC 2 Type II (Security) vendor
- Consistency strong consistency required for clinical record integrity vendor
- Versioning immutable audit log (HIPAA + 21 CFR Part 11 require audit trails) vendor
- Schema evolution FHIR/HL7-aligned schema (clinical standard); minor versioning vendor
- Namespace primitives tenant-per-customer (BAA-scoped); patient-scoped within tenant vendor
- Validated verticals healthcare (ambient documentation, clinical decision support, primary care, oncology) vendor
- Time to running <1week to weeks-to-months (HIPAA-regulated enterprise procurement + EHR integration) vendor
- Anti-fit not for non-healthcare verticals; must operate under HIPAA / regional health regulation vendor
- Optimised for HIPAA compliance + clinical-grade provenance + EHR integration vendor
- Adjacent infrastructure requires EHR integration + clinical workflows vendor
- Pros Most-used clinical-evidence AI in US; memory of past consults + visits feeds longitudina… vendor
- Cons US-clinician scope; smaller global presence; subscription model. vendor
- Project & sources openevidence.com vendor
- architecture-deployment-locus cloud vendor
- licensing-bucket commercial third-party
- positioning-platform-vs-product product vendor
- taxonomy-three-layer-rollup agent-infra repo
What changed
Changes to this record's lifecycle, licence, release, pricing and hosting facts, from the catalog's git history. Subscribe (Atom)
- 2026-10-22
- Pricing first recorded as “Free for verified physicians/HCPs; ad-supported” source
- Funding / ownership first recorded as “~$700M+ total; $250M Series D at $12B val (2026-01); reported further $250M at $15B (2026-09, unconfirmed)” source
- Deployment first recorded as “Managed-only (web + mobile apps)” source